[Clinical pharmacology and pharmacokinetics of pentoxifylline].
Mueller
R
R
Gruppo di studio per l'emoreologia, Wiesbaden, Repubblica Federale Tedesca.
D001773:Blood Cells / Q000187:drug effects; D001808:Blood Vessels / Q000187:drug effects; D004341:Drug Evaluation; D011464:Epoprostenol / Q000096:biosynthesis; D005343:Fibrinolytic Agents / Q000494:pharmacology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008833:Microcirculation / Q000187:drug effects; D015394:Molecular Structure; D010431:Pentoxifylline / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology; D011183:Postoperative Complications / Q000517:prevention & control; D013805:Theobromine / Q000031:analogs & derivatives; D014656:Vascular Surgical Procedures
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D011464:Epoprostenol; D013805:Theobromine; D010431:Pentoxifylline
Aspetti di farmacologia clinica e farmacocinetica della pentossifillina.